<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Centre for Brain Repair</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EBF62057-C51F-47BB-9B80-D3AA4A7ACD29"><gtr:id>EBF62057-C51F-47BB-9B80-D3AA4A7ACD29</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>B.</gtr:otherNames><gtr:surname>Dunnett</gtr:surname><gtr:orcidId>0000-0003-1826-1578</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8678F00A-3BE6-4337-B718-79038B60DC50"><gtr:id>8678F00A-3BE6-4337-B718-79038B60DC50</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:surname>Barker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B7296B44-D98A-4E67-8053-E7E99D157D05"><gtr:id>B7296B44-D98A-4E67-8053-E7E99D157D05</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Douglas</gtr:otherNames><gtr:surname>Pickard</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/53E7EF11-FCED-4F39-89E8-38E69990FC29"><gtr:id>53E7EF11-FCED-4F39-89E8-38E69990FC29</gtr:id><gtr:firstName>Anne Elizabeth</gtr:firstName><gtr:surname>Rosser</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9825903"><gtr:id>6825DB3C-A3F0-4735-87B5-D4BDFE945F07</gtr:id><gtr:title>Safety and feasibility of neural transplantation in early to moderate Huntington's disease in the UK.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9825903</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>294804</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6770334F-B68E-4BE0-969A-AAEF0209919E</gtr:id><gtr:impact>I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:outcomeId>23C57C21F20</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>CADDEF37-ABDB-49C2-9EF3-36CE350DB4E5</gtr:id><gtr:impact>10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:outcomeId>4E533867798</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>results included in multiple public and academic lectures and seminars</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32A74726-2F01-40E4-B56D-302E6F20AD08</gtr:id><gtr:impact>results included in multiple public and academic lectures and seminars

various</gtr:impact><gtr:outcomeId>2B80FAEA334</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7738C2EE-DFD9-41BF-B9F2-C8DC4AEC1338</gtr:id><gtr:impact>10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

academic, medical and patient contacts</gtr:impact><gtr:outcomeId>014EB56EA63</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>A7A6E81F-25FE-4D87-BAE5-A3374A52FA10</gtr:id><gtr:impact>I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:outcomeId>757CF680ED8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>results included in multiple public and academic lectures and seminars</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>93491CA6-37BF-4396-86D2-F7CBE8B29008</gtr:id><gtr:impact>results included in multiple public and academic lectures and seminars

various</gtr:impact><gtr:outcomeId>A1F186CD181</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2941590</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>50E17A2A-0729-4BD5-B31B-141102B11626</gtr:id><gtr:outcomeId>E9F39960E7C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>161923</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PDS international collaboration</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>A8557AE4-0ED8-465F-B8EB-7766EF9A30D1</gtr:id><gtr:outcomeId>9F633B8E4B60</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>873507</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>REPLACES Restorative plasticity at corticostriatal excitatory synapses (4.2m euros across 12 participants)</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>A5DD3543-6336-4803-B00D-58B7F3793F2D</gtr:id><gtr:outcomeId>AFB44C285B60</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>4CB78720-F39E-47E9-A1EA-19E409A5476D</gtr:id><gtr:impact>member of GTAC committee reviewing applications and developing policy on stem cell and gene therapy trials in the UK</gtr:impact><gtr:outcomeId>80395A16996</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC stem cells</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>117EFD8E-CAE1-4EE3-BDE9-EEBC60FD2228</gtr:id><gtr:impact>I participate in the MRC Stem Cell Bank User's group and participate regularly in MRC stem cell policy and funding strategy meetings at Head Office.</gtr:impact><gtr:outcomeId>046F92CC2E5</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>5AFE4F13-D901-4833-ADCB-A3ED7AC67646</gtr:id><gtr:impact>development of national ethical and regulatory guidelines</gtr:impact><gtr:outcomeId>2F7263565E5</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citations in clinical guidelines and reviews</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B41D807F-A2E1-40FF-A3AF-678D96EB4C4B</gtr:id><gtr:impact>we contribute to ongoing debate and updating of guidelines on ethical sourcing of human fetal tissues for research and clinical cell transplantation.</gtr:impact><gtr:outcomeId>0A7A1912D35</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>8B1D69C8-B405-46FC-A224-D43B7552614D</gtr:id><gtr:impact>Targetted direction, policy and funding of UK stem cell research .</gtr:impact><gtr:outcomeId>5AA8378353A</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>regular citations in clinical reviews and publications</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>44046728-5B32-4E2F-A00E-574904BFE3A6</gtr:id><gtr:impact>influence on development of NECTAR and ASNTR guidelines</gtr:impact><gtr:outcomeId>35DB9587696</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC stem cell</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>8556F113-A01F-43C9-934B-C46217C9C876</gtr:id><gtr:impact>I participate in the MRC Stem Cell Bank User's group and participate regularly in MRC stem cell policy and funding strategy meetings at Head Office.</gtr:impact><gtr:outcomeId>F2D8A6F3BAF</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Stem Cells</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>B67156E6-6E3E-43F7-870F-CCC3EAEA7E13</gtr:id><gtr:impact>I participate in the MRC UK Stem Cell Bank users group and contribute regularly to the policy discussions at head office on stem cell strategy and funding.</gtr:impact><gtr:outcomeId>7E9135DE564</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Validation of alternative protocols for consented collection of human fetal tissue</gtr:description><gtr:id>026D1CB4-A1FE-428E-A8B1-55E015213212</gtr:id><gtr:impact>Resolves the outstanding block on limited tissue availability to allow multiple international research and clinical trials to resume.</gtr:impact><gtr:outcomeId>CD8A8553171</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mTOPs</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>09E4F447-AF7D-40CE-9E65-C6346025738C</gtr:id><gtr:title>The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5569c761d204c6033a9730736dccfe4c"><gtr:id>5569c761d204c6033a9730736dccfe4c</gtr:id><gtr:otherNames>Barker RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_14019_29_23345280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F25143EB-5390-429D-B559-D4A1C775BB5E</gtr:id><gtr:title>Task-specific training in Huntington disease: a randomized controlled feasibility trial.</gtr:title><gtr:parentPublicationTitle>Physical therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/836ab228d0a2d9cab611cd19460e2edc"><gtr:id>836ab228d0a2d9cab611cd19460e2edc</gtr:id><gtr:otherNames>Quinn L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-9023</gtr:issn><gtr:outcomeId>54b85cf3371796.01580965</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9825903</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>0CDFB83C-594C-4860-B0BE-C82CA4D45B6B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>